Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis

被引:0
|
作者
GA Hale
DE Reece
RK Munn
AB Kniska
GL Phillips
机构
[1] Markey Cancer Center,Division of Blood and Marrow Transplantation
[2] University of Kentucky,undefined
来源
关键词
tacrolimus; plasmapheresis; pharmacokinetics; GVHD; BMT; microangiopathic hemolytic anemia;
D O I
暂无
中图分类号
学科分类号
摘要
Microangiopathic hemolytic anemia (MAHA) is a well-described complication of stem cell transplantation. Plasmapheresis is one modality utilized as therapy for patients who develop this complication. However, plasmapheresis may alter whole blood levels of certain medications and its effect on tacrolimus in bone marrow transplant patients is unknown. Because tacrolimus has a narrow therapeutic range, the effect of plasmapheresis on whole blood concentrations would be important to know. We report three allogeneic BMT patients who were receiving tacrolimus as acute GVHD therapy while undergoing plasmapheresis for MAHA. Tacrolimus levels seemed unaffected by plasmapheresis in these patients. Bone Marrow Transplantation (2000) 25, 449–451.
引用
收藏
页码:449 / 451
页数:2
相关论文
共 50 条
  • [1] Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis
    Hale, GA
    Reece, DE
    Munn, RK
    Kniska, AB
    Phillips, GL
    BONE MARROW TRANSPLANTATION, 2000, 25 (04) : 449 - 451
  • [2] Monitoring of whole blood tacrolimus (T) concentrations in allogeneic bone marrow/progenitor cell transplant patients.
    Kennedy, LD
    Kuzma, K
    Case, LD
    Cruz, JM
    High, KP
    Keung, YK
    Zamkoff, KW
    Hurd, DD
    BLOOD, 2000, 96 (11) : 399A - 399A
  • [3] Analysis of tacrolimus blood concentrations in renal transplant patients
    Wang, C. Y.
    Xu, X.
    Li, M. C.
    Li, Q.
    Ji, S. G.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 3791 - 3797
  • [4] CONCURRENT POSACONAZOLE AND TACROLIMUS USE IN PEDIATRIC PATIENTS: A RETROSPECTIVE REVIEW TO DETERMINE TIME TO THERAPEUTIC TACROLIMUS CONCENTRATIONS IN PEDIATRIC BONE MARROW TRANSPLANT PATIENTS
    Chu, Jane
    Patel, Arpita
    Echols, Carmen
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S199 - S199
  • [5] Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A
    Sarkodee-Adoo, C
    Sotirescu, D
    Sensenbrenner, L
    Rapoport, AP
    Cottler-Fox, M
    Tricot, G
    Ruehle, K
    Meisenberg, B
    TRANSFUSION, 2003, 43 (01) : 78 - 84
  • [6] Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients
    Venkataramanan, R
    Shaw, LM
    Sarkozi, L
    Mullins, R
    Pirsch, J
    MacFarlane, G
    Scheller, D
    Ersfeld, D
    Frick, M
    Fitzsimmons, WE
    Virji, M
    Jain, A
    Brayman, KL
    Shaked, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (05): : 542 - 551
  • [7] CYCLOSPORINE METABOLITE CONCENTRATIONS IN THE BLOOD OF LIVER, HEART, KIDNEY, AND BONE-MARROW TRANSPLANT PATIENTS
    WANG, CP
    BURCKART, GJ
    PTACHCINSKI, RJ
    VENKATARAMANAN, R
    SCHWINGHAMMER, T
    HAKALA, T
    GRIFFITH, B
    HARDESTY, R
    SHADDUCK, R
    KNAPP, J
    VANTHIEL, DH
    MAKOWKA, L
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) : 591 - 596
  • [9] Change in blood tacrolimus concentration by fluctuation of renal function in a bone marrow transplant patient
    Sumi, Masaki
    Konishi, Hiroki
    Ikuno, Yoshihiro
    Hoshino, Nobuo
    Minouchi, Tokuzo
    Yamaji, Akira
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2009, 34 (3-4) : 201 - 204
  • [10] Change in blood tacrolimus concentration by fluctuation of renal function in a bone marrow transplant patient
    Masaki Sumi
    Hiroki Konishi
    Yoshihiro Ikuno
    Nobuo Hoshino
    Tokuzo MiNouchi
    Akira Yamaji
    European Journal of Drug Metabolism and Pharmacokinetics, 2009, 34 : 201 - 204